Ola Soderquist - 31 Dec 2021 Form 5 Insider Report for BIOXYTRAN, INC (BIXT)

Role: CFO, 10%+ Owner
Signature: /s/ Ola Soderquist
Issuer symbol: BIXT
Transactions as of: 31 Dec 2021
Net transactions value: +$38,125
Form type: 5
Filing time: 28 Jan 2022, 13:20:11 UTC
Previous filing: 18 Jan 2022
Next filing: 07 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIXT	Common	Award	$54,672	+227,800	+1.1%	$0.2400	20,363,100	15 Jan 2021	Direct
transaction	BIXT	Common	Award	$386,618	+2,973,988	+15%	$0.1300	23,337,088	04 Jun 2021	Direct
transaction	BIXT	Common	Gift	$441,847	-3,201,788	-14%	$0.1380	20,135,300	18 Nov 2021	Direct	F1
transaction	BIXT	Common	Award	$2,681	+1,340,749	+6.7%	$0.002000^*	21,476,049	03 Dec 2021	by NDPD Pharma, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIXT	Warrant	Award	$36,000	+100,000		$0.3600	100,000	02 May 2021	Common	100,000	$2.00	by NDPD Pharma, Inc.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares returned to Company's treasury
F2	The warrant agreement includes provisions for dilutive issuance and cash-less exercise